Clinical Trials Directory

Trials / Completed

CompletedNCT03607344

Day Case Laparoscopic Sacrocolpopexy, a New Management

Day-case Laparoscopic Sacrocolpopexy, a Compelling Option in Selected Patients

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
Female
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Facing the stakes of hospital beds, this study assessed day case variant technic of laparoscopic sacrocolpopexy with or without robotic assistant.

Detailed description

Pelvic organ prolapse (POP) is an increasingly common functional disorder which affects approximately 40% of female population. Of these 12% are symptomatic and suffer of physical and emotional distress. 11% will undergo a surgical procedure. Since its introduction by Lane in 1982, Sacrocolpopexy (SCP) became the surgical "gold standard" for correcting vaginal vault . With minimal invasive approach, SCP had an mean hospitalization time of 3 to 7 days . With rising health care cost and its inherent economic burden, safe and viable options to reduce cost must be sought. Day case surgery has developed rapidly in the USA since the 1970s, and has spread to Europe, especially in Great Britain. But the High Authority of Health in France found a delay in its development. In view of the evolution of surgical and anesthetic techniques, and the low complication rate of SCP, it seemed natural to imagine that this intervention could be done in an ambulatory setting.

Conditions

Interventions

TypeNameDescription
PROCEDURECohortPatients undergoing ambulatory laparoscopic sacrocolpopexy

Timeline

Start date
2016-01-01
Primary completion
2016-01-26
Completion
2018-06-30
First posted
2018-07-31
Last updated
2018-07-31

Source: ClinicalTrials.gov record NCT03607344. Inclusion in this directory is not an endorsement.